Teva Takeda Pharma and Teva Takeda Yakuhin said on January 30 that they are restricting their shipments of eight products as the New Year’s earthquake caused delays in the deliveries of some products from a contract manufacturer.
The companies decided on the move to ensure stable drug supplies amid the delivery delay from Kokando. Subject to the restrictions are one product owned by Teva Takeda Pharma as the marketing authorization holder, Candesartan Tablets 8 mg “Takeda Teva”, as well as seven products held by Teva Takeda Yakuhin - Cercine Tablets 2 mg (diazepam), Takelda Combination Tablets (lansoprazole + aspirin), Ecard Combination Tablets LD/HD (candesartan + hydrochlorothiazide), Takepron OD Tablets 15/30 (lansoprazole), and Blopress Tablets 2 (candesartan).